SECUKINUMAB 150 mg in 1mL Injection, SECUKINUMAB 300 mg in 2mL Solution for Injection
key details
| Status | complete |
|---|---|
| Region | Northern Ireland |
| Procedure | direct |
| OCID | ocds-h6vhtk-05ddfe |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| NOVARTIS PHARMACEUTICALS UK LIMITED | £4,638,166 | 10 Nov 2025 | active |
description
Supply of SECUKINUMAB (COSENTYX) 150 mg in 1mL & 300mg in 2mL Injections to meet clinical need in the Western Trust until 30/11/2028.
notice history
3 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 10 Nov 2025 | Transparency notice (UK5) | Procurement Act 2023 | 072520-2025 |
| 10 Nov 2025 | Contract award (UK6) | Procurement Act 2023 | 072544-2025 |
| 8 Dec 2025 | Contract details (UK7) | Procurement Act 2023 | 080590-2025 |
more from Western Health & Social Care Trust
- Provision of an Emergency Department ICT tracking System · 20 Jul 2026
- Provision of software support to utilise real asset management software · 10 Jul 2026
- Provision of an Emergency Department ICT tracking System · 16 Jun 2026
- Pre Market Engagement for Microbiology Molecular Platforms, Consumables and Quality Control Products · 11 May 2026
- Service and Maintenance of Bracco Equipment · 5 May 2026
- TRASTUZUMAB DERUXTECAN 100MG POWDER FOR CONCENTRATE FOR SOLN FOR INFUSION · 22 Apr 2026
- Provision of an Emergency Department ICT tracking System for decommissioning and read only data upgrade · 14 Apr 2026
- TRIFLURIDINE 15MG AND TIPIRACIL 6.14MG TABLETS; TRIFLURIDINE 20MG AND TIPIRACIL 8.19MG TABLETS · 16 Mar 2026
all contracts from this buyer →
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.